From 50 to 500 genes: How to Scale to Comprehensive Genomic Profiling While Reducing Cost, Time and Labor

In the next five years, the majority of clinical diagnostic labs competing to offer NGS oncology testing will be performing comprehensive genomic profiling (CGP). Yet scaling to CGP introduces unique challenges that clinical diagnostic labs must overcome, such as contending with exponentially more variants, encountering a greater number of incidental germline findings and variants that are less characterized, and accurately interpreting co-occurring variants that interact with each other to impact prognosis, diagnosis and treatment responses.

In this webinar, we present a workflow-agnostic, informatics software solution that enables clinical diagnostic labs to scale to CGP while reducing cost, time, and labor. Already used and trusted to interpret over 3 million patient cases worldwide, this software solution leverages the world’s largest and fastest growing knowledge base to simplify and accelerate variant interpretation and build custom, patient-specific reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.

When you attend this webinar, you will:
• Learn how to overcome unique challenges of CGP, including identifying incidental germline findings and interpreting co-occurring variants.
• See why 90,000 users trust QIAGEN Digital Insights for knowledge curation—how we have built the most trusted, fastest growing knowledge base and why our curation process is unrivalled in the industry.
• Receive step-by-step guide of how to perform CGP and go from VCF to final report with greater speed, precision, and confidence (all registrants can receive custom report if VCF files are provided).
• Qualify for a complimentary demonstration and trial of this industry-leading software to see how your lab can scale to CGP while reducing costs, time, and labor.